We're all aware of reasons to favour outsourcing at this time whether they be challenging price restrictions, US health care reforms or reduced revenues. But, do we know the best way to maintain our standards when this move is made?
Delivering COG reduction and efficiency gains through external manufacturing and procurement strategies
26-27 September 2011, Berlin, Germany
Pharmaceutical Technology Europe subscribers get 20% off
Register your place now for £1036 and save £259 quoting booking code PTEE1.
We're all aware of reasons to favour outsourcing at this time whether they be challenging price restrictions, US health care reforms or reduced revenues. But, do we know the best way to maintain our standards when this move is made?
Managing relationships, maintaining quality standards, negotiating the best deals and meeting regulations are all considerations that have to be taken.
This summit will discuss all of the issues above with senior professionals who have gone through the process and can provide unique insight into the potential pitfalls and the most effective strategies.
So who will you hear from?
Speakers include:
Giles Breault, Chief Purchasing Officer, Novartis
And what will be discussed?
Key topics:
Building & Maintaining a profitable and robust outsourcing relationship How to negotiate the best outsourcing deals Successfully outsourcing to China Using audit strategies to aid your outsourcing requirements Overcoming cultural, language and distance barriers in outsourcing
Interested?
To register your place now visit www.outsourcingevent.com/PTEE1, call +44 (0)20 7202 7690 or email magdalena.musial@wtgevents.com for the special 20% discount courtesy of Pharmaceutical Technology Europe and remember to quote the booking reference PTEE1.
Diving Deep into Carrier-Based Formulation and Process Optimization
December 23rd 2024Carrier-based formulations for dry powder inhalers are carefully designed to transport extremely small particles into the lungs. Jet milling can be used to micronize these particles, with both high and low shear mixing processes used to formulate mixtures capable of carrying the fine API particles into the deep lung. This paper looks at the requirements for pulmonary delivery via carrier-based inhaled powder formulations, and how jet milling can be used to manufacture effective and stable materials for these formulations